Last reviewed · How we verify
Steve Yoelin M.D. Medical Associates, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Aesthetics / Neurology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- ATGC Co., Ltd. · 1 shared drug class
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Brigitte Schürch · 1 shared drug class
- Carruthers Dermatology Centre · 1 shared drug class
- Department of Medical Services Ministry of Public Health of Thailand · 1 shared drug class
- Galderma R&D · 1 shared drug class
- Huons Co., Ltd. · 1 shared drug class
- Innovaderm Research Inc. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Steve Yoelin M.D. Medical Associates, Inc.:
- Steve Yoelin M.D. Medical Associates, Inc. pipeline updates — RSS
- Steve Yoelin M.D. Medical Associates, Inc. pipeline updates — Atom
- Steve Yoelin M.D. Medical Associates, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Steve Yoelin M.D. Medical Associates, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/steve-yoelin-m-d-medical-associates-inc. Accessed 2026-05-17.